Late Infantile Neuronal Ceroid Lipofuscinosis and Dopamine Deficiency

被引:8
作者
Le, Ngoc Minh D. [1 ]
Parikh, Sumit [1 ]
机构
[1] Cleveland Clin, Ctr Pediat Neurol, Cleveland, OH 44195 USA
关键词
epilepsy; neuronal ceroid lipofuscinosis; neurotransmitter; dopamine; bioprotein; lysosomal disorder; SOUTH HAMPSHIRE SHEEP; BATTEN-DISEASE; MOUSE MODEL; GENE; DISORDERS; DIAGNOSIS; MUTATION;
D O I
10.1177/0883073811419261
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuronal ceroid lipofuscinosis is a severe neurodegenerative lysosomal storage disorder. Gamma-aminobutyric acid and glutamate deficiency have been reported with CLN1, CLN3, and CLN6. Isolated biopterin/neopterin without dopamine deficiency has been reported in 1 patient with a CLN2 mutation. This report describes a patient with a CLN2 mutation with symptomatic biopterin and dopamine deficiency. A 4-year-old boy presented with intractable epilepsy and developmental regression starting 1 year previously. His exam showed retinopathy, scanning speech, dysmetria, and ataxic fenestrating gait with stooped posture. Electroencephalogram showed generalized spikes with occipital spikes on slow photic stimulation. Brain magnetic resonance images 1 year apart showed significant diffuse atrophy. CLN2 gene sequencing showed pathogenic compound heterozygous mutations. Cerebrospinal fluid neurotransmitters showed low homovanillic acid and tetrahydrobiopterin. Levodopa-carbidopa resulted in dramatic improvement of gait. Dopamine/biopterin deficiency is a possible secondary manifestation of CLN2 mutations. Levodopa and dopamine agonists might be useful in treating these secondary abnormalities and improving quality of life in these patients.
引用
收藏
页码:234 / 237
页数:4
相关论文
共 24 条
[1]   A favorable response to antiparkinsonian treatment in juvenile neuronal ceroid lipofuscinosis [J].
Åberg, LE ;
Rinne, JO ;
Rajantie, I ;
Santavuori, P .
NEUROLOGY, 2001, 56 (09) :1236-1239
[2]  
Barisic N, 2003, CROAT MED J, V44, P489
[3]   Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia [J].
Bonafé, L ;
Thöny, B ;
Penzien, JM ;
Czarnecki, B ;
Blau, N .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (02) :269-277
[4]   Tyrosine hydroxylase deficiency presenting with a Biphasic Clinical Course [J].
Giovanniello, T. ;
Leuzzi, V. ;
Carducci, C. ;
Carducci, C. ;
Di Sabato, M. L. ;
Artiola, C. ;
Santagata, S. ;
Pozzessere, S. ;
Antonozzi, I. .
NEUROPEDIATRICS, 2007, 38 (04) :213-215
[5]   The neuronal ceroid-lipofuscinoses: From past to present [J].
Haltia, Matti .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2006, 1762 (10) :850-856
[6]   Neuronal ceroid lipofuscinoses [J].
Jalanko, Anu ;
Braulke, Thomas .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (04) :697-709
[7]  
Ju Weina, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P41
[8]   Towards understanding the neuronal ceroid lipofuscinoses [J].
Kohlschuetter, Alfried ;
Schulz, Angela .
BRAIN & DEVELOPMENT, 2009, 31 (07) :499-502
[9]   Biochemical diagnosis of dopaminergic disturbances in paediatric patients: Analysis of cerebrospinal fluid homovanillic acid and other biogenic amines [J].
Marin-Valencia, Isaac ;
Serrano, Mercedes ;
Ormazabal, Aida ;
Perez-Duenas, Belen ;
Garcia-Cazorla, Angels ;
Campistol, Jaume ;
Artuch, Rafael .
CLINICAL BIOCHEMISTRY, 2008, 41 (16-17) :1306-1315
[10]   Neuronal ceroid lipofuscinoses (NCL) [J].
Mole, Sara E. .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2006, 10 (5-6) :255-257